tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Berens, 154 are a BUY (69.06%), 49 are a HOLD (21.97%), 20 are a SELL (8.97%).
Analyst Andrew Berens works at LEERINK with a stock forecast success ratio of 49.67% fulfilled within 171.26 days on average.
Andrew Berens’s has documented 431 price targets and ratings displayed on 38 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on INCY, yte at 13-Dec-2023.
Analyst best performing recommendations are on ELEV (ELEVATION ONCOLOGY).
The best stock recommendation documented was for ELEV (ELEVATION ONCOLOGY) at 1/9/2023. The price target of $1 was fulfilled within 3 days with a profit of $0.2 (25%) receiving and performance score of 83.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
30
$-1.67 (-5.27%)
32
2 months 3 days ago
3/3 (100%)
$-2.99 (-9.06%)
224
Hold
28
$-3.67 (-11.59%)
32
5 months 23 days ago
6/6 (100%)
$5.51 (24.50%)
192
Buy
42
$10.33 (32.62%)
67
9 months 30 days ago
5/12 (41.67%)
$13.87 (49.31%)
213
Buy
38
$6.33 (19.99%)
40
9 months 30 days ago
0/4 (0%)
$9.87 (35.09%)
Buy
37
$5.33 (16.83%)
33
1 years 8 months 21 days ago
6/11 (54.55%)
$7.26 (24.41%)
69
Which stock is Andrew Berens is most bullish on?
Which stock is Andrew Berens is most reserved on?
What Year was the first public recommendation made by Andrew Berens?
